Brystkreftkirurgi i Norge 1986-2009

Tidsskrift for den Norske Laegeforening

Volumn 133, Issue 15, 2013, Pages 1582-1586

  Hofvind, Solveig ^a   Schlichting, Ellen ^b   Ursin, Giske ^a,b,d   Sebuødegård, Sofie ^a   Kåresen, Rolf ^c  

^a OSLO METROPOLITAN UNIVERSITY   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BREAST TUMOR; FEMALE; HUMAN; INTRADUCTAL CARCINOMA; MASTECTOMY; MIDDLE AGED; NORWAY; REGISTER; SEGMENTAL MASTECTOMY; STATISTICS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS; MASTECTOMY; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NORWAY; REGISTRIES;

EID: 84884363275     PISSN: 00292001     EISSN: 08077096     Source Type: Journal    
DOI: 10.4045/tidsskr.12.0840     Document Type: Article

References (29)

1. Parkin DM, Bray F, Ferlay J et al. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2. Kreftregisteret. Cancer in Norway 2009-Cancer incidence, mortality, survival and prevalence in Norway. Oslo: Kreftregisteret, 2011.
3. Blåboka. www.nbcg.no/nbcg.blaaboka.html (7.1.2013).
4. Schlichting E, Harr ME, Sauer T et al. Vaktpostlymfeknuteoperasjon ved brystkreft. Tidsskr Nor Lægeforen 2006; 126: 2098-100.
5. Kalager M, Kåresen R, Wist E. Fylkesvise forskjeller i overlevelse av brystkreft. Tidsskr Nor Legeforen 2009; 129: 2595-600.
6. Veronesi U, Cascinelli N, Mariani L et al. Twentyyear follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002; 347: 1227-32.
7. Fisher B, Anderson S, Bryant J et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002; 347: 1233-41.
8. Clarke M, Collins R, Darby S et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 366: 2087-106.
9. Litière S, Werutsky G, Fentiman IS et al. Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. Lancet Oncol 2012; 13: 412-9.
10. Hwang ES, Lichtenzstajn DY, Gomez SL et al. Survival after lumpectomy and mastectomy for early stage invasive breast cancer: the effect of age and hormone receptor status. Cancer 2013; 119: 1402-11.
11. Suhrke P, Mæhlen J, Schlichting E et al. Effect of mammography screening on surgical treatment for breast cancer in Norway: comparative analysis of cancer registry data. BMJ 2011; 343: d4692.
12. Larsen IK, Småstuen M, Johannesen TB et al. Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer 2009; 45: 1218-31.
13. Sørum R, Hofvind S, Skaane P et al. Trends in incidence of ductal carcinoma in situ: the effect of a population-based screening programme. Breast 2010; 19: 499-505.
14. Lundgren S, Jørgensen S, Kåresen R. Brystkreftkirurgi i Norge 1990-95 belyst med data fra SINTEF Unimed. Tidsskr Nor Lægeforen 2001; 121: 2688-93.
15. Tejler G, Norberg B, Dufmats M et al. Survival after treatment for breast cancer in a geographically defined population. Br J Surg 2004; 91: 1307-12.
16. Kåresen R. Brystkreft. Tidsskr Nor Lægeforen 1997; 117: 3763-4.
17. Peto R, Boreham J, Clarke M et al. UK and USA breast cancer deaths down 25 % in year 2000 at ages 20-69 years. Lancet 2000; 355: 1822.
18. Verschraegen C, Vinh-Hung V. Effects of radiotherapy and surgery for early breast cancer. Lancet 2006; 367: 1654-5.
19. Miles RC, Gullerud RE, Lohse CM et al. Local recurrence after breast-conserving surgery: multivariable analysis of risk factors and the impact of young age. Ann Surg Oncol 2012; 19: 1153-9.
20. Johnson L, Pinder S, Douek M. Multiple foci of invasive breast cancer: can breast MRI influence surgical management? Breast Cancer Res Treat 2011; 128: 1-5.
21. Rosenkranz K. Multiple ipsilateral breast cancers: current strategies for surgical management. Curr Breast Cancer Rep 2012; 4: 148-52.
22. Dragun AE, Pan J, Riley EC et al. Increasing use of elective mastectomy and contralateral prophylactic surgery among breast conservation candidates: a 14-year report from a comprehensive cancer center. Am J Clin Oncol 2012.. E-publisert 24.5.
23. Houssami N, Macaskill P, Marinovich ML et al. Meta-analysis of the impact of surgical margins on local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy. Eur J Cancer 2010; 46: 3219-32.
24. Falk RS, Hofvind S, Skaane P et al. Second events following ductal carcinoma in situ of the breast: a register-based cohort study. Breast Cancer Res Treat 2011; 129: 929-38.
25. Hofvind S, Lee CI, Elmore JG. Stage-specific breast cancer incidence rates among participants and non-participants of a population-based mammographic screening program. Breast Cancer Res Treat 2012; 135: 291-9.
26. Møller P, Hagen AI, Apold J et al. Genetic epidemiology of BRCA mutations-family history detects less than 50 % of the mutation carriers. Eur J Cancer 2007; 43: 1713-7.
27. Opsahl EM, Westre B, Samset JH et al. Brystkreft-diagnostikk og behandling ved Ålesund sjukehus. Tidsskr Nor Legeforen 2010; 130: 724-8.
28. Veronesi U, Orecchia R, Luini A et al. Intraoperative radiotherapy during breast conserving surgery: a study on 1,822 cases treated with electrons. Breast Cancer Res Treat 2010; 124: 141-51.
29. Vaidya JS, Joseph DJ, Tobias JS et al. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial. Lancet 2010; 376: 91-102.